What is Janux Therapeutics's investment proceeds?

Janux Therapeutics (JANX) reported investment proceeds of $121.31M in Q1 2026.

How has Janux Therapeutics's investment proceeds changed year-over-year?

Janux Therapeutics's investment proceeds increased by 287.9% year-over-year, from $31.27M to $121.31M.

What is the long-term trend for Janux Therapeutics's investment proceeds?

Over 4 years (2021 to 2025), Janux Therapeutics's investment proceeds has grown at a 31.8% compound annual growth rate (CAGR), from $134.15M to $405.28M.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

Janux Therapeutics JANX Investment Proceeds

Investment Proceeds at other companies

XencorXNCR

$99.97M-16.0%

Nektar TherapeuticsNKTR

$101.48M+46.4%

ImmunomeIMNM

$0-100%

CRISPR TherapeuticsCRSP

$175.5K—

Summit TherapeuticsSMMT

$177.29M+10.4%

ImmunityBio, Inc.IBRX

$79.38M+1,384%

Other financials

Income statement

See full

Revenue$3.7M—

Operating income-$34.2M+2.0%

Net income-$24.4M-3.6%

EPS (diluted)-$0.39-2.6%

Balance sheet

See full

Cash & equivalents$51.8M-29.7%

Total debt$21.6M-4.6%

Total equity$941.5M-7.0%

Total assets$1.0B-2.1%

Cash flow

See full

Operating cash flow-$12.3M+27.5%

CapEx$273.0K-26.4%

Free cash flow-$12.6M+27.5%

Valuation

See full

Market cap$892.81M-36.3%

Enterprise value$862.55M-36.2%

P/S65×-85.2×

Profitability

See full

Operating margin-1,143.1%-65.1pp

Net margin-833.6%+0.9pp

FCF margin-571.6%+98.3pp

Returns & leverage

See full

Return on equity-11.7%+4.1pp

Debt / equity0×0.0×

Current ratio17×-41.5×

Where this comes from

Reported directly by Janux Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments.

The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janux Therapeutics's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Janux Therapeutics's investment proceeds?: Janux Therapeutics (JANX) reported investment proceeds of $121.31M in Q1 2026.
How has Janux Therapeutics's investment proceeds changed year-over-year?: Janux Therapeutics's investment proceeds increased by 287.9% year-over-year, from $31.27M to $121.31M.
What is the long-term trend for Janux Therapeutics's investment proceeds?: Over 4 years (2021 to 2025), Janux Therapeutics's investment proceeds has grown at a 31.8% compound annual growth rate (CAGR), from $134.15M to $405.28M.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.